Respirair and Dechra announce veterinary anesthesia collaboration
Partnership aims to create a powerful new force in veterinary anesthesia
Respirair Global has established a strategic alliance with Dechra in the USA for Isoflurane and Sevoflurane veterinary vaporizers and anesthesia accessories.
“Innovation and collaboration are at the heart of this partnership”, said Neil Redmayne, CEO of Respirair, in a company release.1 “We are striving to raise the bar on quality, service, sustainability and value by bringing high quality, affordable products, with an innovative 360-degree wraparound service package to the US veterinary market”.
According to the release, the Respirair vaporiser comes with a warranty of 6 years, backed up by a Respirair Global service center. The Respirair vaporiser provides thermal dynamics, a coating process for anticorrosion protection, more durable thermostats than available prior, and each are tested to significantly tighter tolerances than industry standard. Every product variant comes in all fitting and filler options.1
“We are pleased to have partnered with Respirair Global to provide veterinarians with high quality and affordable anesthesia equipment, along with our low-cost general aesthetics agents, isoflurane and sevoflurane," commented Mike Eldred, president of Dechra North America, in the release.1
"This partnership further strengthens our position as a leader in the veterinary surgical suite market segment, he concluded.
Reference
Respirair and Dechra - US veterinary anaesthesia partnership. News release. Respirair. April 13, 2022. Accessed April 14, 2022.
